Loyez, M., Larrieu, J.-C., Chevineau, S., Remmelink, M., LEDUC, D., Bondue, B., Lambert, P., Devière, J., Wattiez, R., & Caucheteur, C. (19 June 2019). Surface Plasmon Resonance in complex media: Optical fibers for in situ cancer diagnosis [Paper presentation]. 6th International Conference on Bio-Sensing Technology, Kuala Lumpur, Malaysia.  Peer reviewed |
  | Kindt, N., Descamps, G., Lechien, J., Remmelink, M., Colet, J.-M., Wattiez, R., Berchem, G., Journe, F., & Saussez, S. (02 February 2019). Involvement of HPV Infection in the Release of Macrophage Migration Inhibitory Factor in Head and Neck Squamous Cell Carcinoma. Journal of Clinical Medicine, 1#0 (8). Peer reviewed |
 | Kindt, N., Descamps, G., Lechien, J., Remmelink, M., Colet, J.-M., Wattiez, R., Berchem, G., Journe, F., & Saussez, S. (2019). Involvement of HPV Infection in the release of macrophage migration inhibitory factor in head and neck squamous cell carcinoma. In Journal of Clinical Medecine. mdpi. |
Loyez, M., Chevineau, S., Larrieu, J.-C., Remmelink, M., Lambert, P., Caucheteur, C., & Wattiez, R. (23 May 2018). Biomarker detection using optical fiber gratings: towards in vivo diagnosis [Poster presentation]. Metamorphose Doctoral School, Louvain-la-Neuve, Belgium. |
Arcolia, V., Journe, F., Renaud, F., Leteurte, E., Gabius, H., Remmelink, M., & Saussez, S. (01 October 2017). Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer. Oncology Letters, 14 (4), 4183-4189. Peer Reviewed verified by ORBi |
  | Arcolia, V., Journe, F., Wattiez, R., Leteurte, E., Renaud, F., Gabius, H., Remmelink, M., Decaestecker, C., Rodriguez, A., Boutry, S., Laurent, S., & Saussez, S. (01 September 2017). Galectin-1 is a diagnostic marker involved in thyroid cancer progression. International Journal of Oncology, 51 (3), 760-770. Peer Reviewed verified by ORBi |
Chevineau, S., Ribaut, C., Pieter, D., Remmelink, M., & Wattiez, R. (07 May 2017). CK17 as a novel biomarker for lung squamous cell carcinoma in vivo diagnosis using optical fiber biosensor [Paper presentation]. 5th International Conference on Bio-Sensing Technology, Riva del Garda, Italy. |
Loyez, M., Ribaut, C., Larrieu, J.-C., Chevineau, S., Lambert, P., Remmelink, M., Wattiez, R., & Caucheteur, C. (07 May 2017). Biomarker sensing using plasmonic optical fibers: Towards in vivo diagnosis [Paper presentation]. 5th International Conference on Bio-Sensing Technology, Riva del Garda, Italy. Peer reviewed |
 | Chevineau, S., Ribaut, C., Pieter, D., Remmelink, M., & Wattiez, R. (07 March 2017). Cytokeratin 17 as a novel biomarker for lung squamous cell carcinoma in vivo diagnosis using optical fiber biosensor [Poster presentation]. Huitième édition montoise du MdC : le Mardi des Chercheurs 2017, UMons, Belgium. |
Arcolia, V., Journe, F., Wattier, A., Leteurtre, E., Gabius, H.-J., Remmelink, M., Decaestecker, C., Rodriguez, A., Boutry, S., Laurent, S., & Saussez, S. (01 July 2016). Galectin-1 as a diagnostic marker involved in thyroid cancer progression [Poster presentation]. Symposium of ULB-Cancer Research Centre (U-CRC), Erasme, Belgium. |
Arcolia, V., Wattier, A., Remmelink, M., Decaestecker, C., & Saussez, S. (30 January 2016). Involvement of galectin-1 in thyroid cancers [Poster presentation]. BACR Annual Meeting, ULB Erasme, Belgium. |
Duray, A., De Maesschalk, T., Decaestecker, C., Remmelink, M., Chantrain, G., Neiveyans, J., Horoi, M., Leroy, X., Gabius, H., & Saussez, S. (2014). Galectin fingerprinting in naso-sinusal diseases. Oncology Reports. Peer Reviewed verified by ORBi |
Arcolia, V., Rifaut, C., Remmelink, M., Laurent, G., & Saussez, S. (12 March 2013). Galectin -1: a new potential biomarker for thyroid cancers [Poster presentation]. 7ème édition de la Matinée de Chercheurs, Mons, Belgium. |
Arcolia, V., Rifaut, C., Remmelink, M., Laurent, G., & Saussez, S. (29 January 2013). Galectin -1: a new potential biomarker for thyroid cancers [Poster presentation]. 1ère journée des doctorants en Sciences Biomédicales et Pharmaceutiques, Mons, Belgium. |
Kindt, N., Lechien, J., Decaestecker, C., Rodriguez, A., Chantrain, G., Remmelink, M., Laurent, G., Gabius, H.-J., & Saussez, S. (12 October 2012). Expression of Macrophage Migration-Inhibitory Factor is Correlated with Progression in Oral Cavity Carcinomas. Anticancer Research, 32 (10), 4499-4506. Peer Reviewed verified by ORBi |
Duray, A., Descamps, G., Decaestecker, C., Remmelink, M., Sirtaine, N., Lechien, J., Ernoux, P., Bletard, N., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (24 April 2012). Human Papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope, 122 (7), 1558-1565. doi:10.1002/lary.23298 Peer Reviewed verified by ORBi |
 | Duray, A., Descamps, G., Arafa, M., Decaestecker, C., Remmelink, M., Sirtaine, N., Ernoux, P., Mutijima, E., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (01 July 2011). High incidence of high-risk HPV in benign and malignant lesions of the larynx. International Journal of Oncology, 39 (1), 51-59. Peer Reviewed verified by ORBi |
 | Remmelink, M., de LEVAL, L., Decaestecker, C., Duray, A., Crompot, E., Sirtaine, N., André, S., Kaltner, H., Leroy, X., Gabius, H.-J., & Saussez, S. (01 March 2011). Quantitative immunohistochemical fingerprinting of adhesion/growth-regulatory galectins in salivary gland tumours: divergent profiles with diagnostic potential. Histopathology, 58 (4), 543-556. Peer Reviewed verified by ORBi |
 | Saussez, S., de Leval, L., Decaestecker, C., Sirtaine, N., Cludts, S., Duray, A., Chevalier, D., André, S., Gabius, H.-J., Remmelink, M., & Leroy, X. (01 May 2010). Galectin fingerprinting in Warthin's tumors: lectin-based approach to trace its origin? Histology and Histopathology, 25, 541-550. Peer Reviewed verified by ORBi |
 | Ernoux, P., Arafa, M., Decaestecker, C., Duray, A., Remmelink, M., Leroy, X., Herfs, M., Somja, J., Depuydt, C., Delvenne, P., & Saussez, S. (08 April 2010). Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. Journal of Cancer Research and Clinical Oncology, 137, 173-181. Peer Reviewed verified by ORBi |
 | Cludts, S., Decaestecker, C., Mahillon, V., Chevalier, D., Kaltner, H., André, S., Remmelink, M., Leroy, X., Gabius, H.-J., & Saussez, S. (01 December 2009). Galectin-8 Upregulation during hypopharyngeal and laryngeal tumor progression and comparison with Galectins-1, -3, -7. Anticancer Research, 29, 4933-4940. Peer Reviewed verified by ORBi |